SPDR S&P Biotech ETF Rating $157.37 +2.87 (+1.86%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Biotech ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy 2.73Holdings in XBI have an aggregate rating of Moderate Buy based on 398 analyst ratings issued in the past year covering 25 companies (31.8% of the portfolio).XBI Aggregate Price Target$157.37High Prediction$157.37Average Prediction$157.37Low Prediction$157.37Holdings in XBI have an aggregate price target of $157.37 and a range of $157.37 to $157.37 covering 25 companies (31.8% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 XBI Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.59%APGEApogee Therapeutics$134.84+0.3%1.8838 of 5 stars2.24$121.25 -10.1%21Upcoming Earnings1.42%ERASErasca$18.41+0.8%2.2455 of 5 stars2.64$21.64 17.5%11Trending NewsUpcoming Earnings1.41%ORKAOruka Therapeutics$98.82+0.4%3.4675 of 5 stars2.82$134.30 35.9%11Upcoming Earnings1.38%KYMRKymera Therapeutics$107.52+1.0%1.9366 of 5 stars2.83$125.65 16.9%23Earnings ReportAnalyst ForecastAnalyst Revision1.35%DNTHDianthus Therapeutics$108.92-0.9%2.2571 of 5 stars2.93$124.27 14.1%14News CoverageEarnings ReportAnalyst Forecast1.34%TWSTTwist Bioscience$115.67+6.0%1.4711 of 5 stars2.70$98.30 -15.0%10Earnings ReportAnalyst Forecast1.31%SYRESpyre Therapeutics$104.91+1.4%2.5653 of 5 stars2.87$110.15 5.0%15News CoverageEarnings ReportAnalyst ForecastInsider TradeGap Up1.31%PRAXPraxis Precision Medicines$360.76-2.5%4.0558 of 5 stars3.00$573.05 58.8%22News CoveragePositive NewsEarnings ReportAnalyst Forecast1.28%RVMDRevolution Medicines$205.15+3.7%1.7671 of 5 stars2.95$153.05 -25.4%22Earnings ReportAnalyst Forecast1.27%CGONCG Oncology$75.10+0.3%2.2107 of 5 stars2.71$83.18 10.8%14Trending NewsEarnings ReportAnalyst ForecastOptions VolumeAnalyst Revision1.26%COGTCogent Biosciences$42.39+1.4%1.4624 of 5 stars2.85$45.90 8.3%13Positive NewsUpcoming Earnings1.26%PTGXProtagonist Therapeutics$145.87-0.2%1.7991 of 5 stars2.94$126.71 -13.1%17Positive NewsEarnings ReportAnalyst ForecastAnalyst Revision1.25%VKTXViking Therapeutics$34.26+2.9%3.4444 of 5 stars2.67$97.88 185.7%121.22%MRNAModerna$59.17+9.9%1.4934 of 5 stars1.88$42.13 -28.8%17Trending NewsEarnings ReportAnalyst Revision1.21%ROIVRoivant Sciences$36.34+3.5%1.6471 of 5 stars2.83$34.77 -4.3%12Trending NewsAnalyst Forecast1.21%BBIOBridgeBio Pharma$84.48+2.0%3.0276 of 5 stars2.82$97.33 15.2%22Upcoming Earnings1.20%ARWRArrowhead Pharmaceuticals$87.65+2.1%2.0432 of 5 stars2.62$97.33 11.0%13Earnings ReportAnalyst ForecastGap Up1.20%CYTKCytokinetics$76.76-5.7%3.5223 of 5 stars2.90$100.85 31.4%21Trending NewsEarnings ReportAnalyst Forecast1.20%NTRANatera$322.10+21.4%2.9819 of 5 stars2.77$299.65 -7.0%22Trending NewsEarnings ReportAnalyst ForecastInsider TradeHigh Trading Volume1.20%PCVXVaxcyte$58.07-1.4%2.7576 of 5 stars2.38$86.00 48.1%8Earnings ReportInsider Trade1.19%RLAYRelay Therapeutics$19.77+0.1%2.9655 of 5 stars2.86$25.17 27.3%14Earnings ReportAnalyst ForecastGap Down1.19%MIRMMirum Pharmaceuticals$100.65+6.9%2.7228 of 5 stars2.93$137.33 36.4%15Trending NewsEarnings ReportAnalyst ForecastInsider Trade1.19%ALKSAlkermes$49.17+1.7%3.055 of 5 stars2.72$54.56 11.0%181.19%TVTXTravere Therapeutics$61.32-1.8%1.7678 of 5 stars2.69$60.18 -1.9%13News CoverageAnalyst Forecast1.18%RYTMRhythm Pharmaceuticals$115.63+3.1%3.0172 of 5 stars2.78$142.44 23.2%18News CoverageEarnings ReportAnalyst Forecast This page (NYSEARCA:XBI) was last updated on 8/7/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XBI Stock Alerts